Project

BMS CA099-003

Ongoing - recruitment closed · 2023 until 2099

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment closed
Start Date
2023
End Date
2099
Financing
Industry
Labels
Phase I
Brief description/objective

A Phase 1/2 Study of BMS-986408 Alone and in Combination with Nivolumab or with Nivolumab and Ipilimumab in Participants with Advanced Solid Tumors